article thumbnail

Amgen Expands In Rhode Island

socalTECH

Thousand Oaks-based biotech giant Amgen is expanding its footprint in Rhode Island, saying on Tuesday that it is opening a new biomanufacturing plant at its West Greenwich, R.I. and global markets. According to Amgen, the new plant will manufacture products for both the U.S.

article thumbnail

Teledyne Increases Stake in Robot Maker Ocean Aero

socalTECH

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Teledyne made its initial investment in Ocean Aero in July of 2014.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Teledyne Buys Majority Stake In Nova Sensors

socalTECH

Thousand Oaks-based Teledyne Technologies said this morning that it has acquired a majority interest in Solvang-based Nova Sensors. Teledyne said the move would bolster its involvement in infrared imaging systems for the commercial and tactical military market. Financial terms of the deal were not disclosed. READ MORE>>.

article thumbnail

Interview with Brett Crosby and Brew Johnson, PeerStreet

socalTECH

I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. Where there are lots of players focused on different types of equity, different types of investments, different types of debt, they're doing it in a very unfocused manner. Brew Johnson: It's exciting to be building this business in LA.

article thumbnail

Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More

Xconomy

Xconomy spoke with CEO Tom Hughes about the decision, which is terrible news for patients with the rare disease Prader-Willi Syndrome; Zafgen had hoped to win FDA approval of beloranib in Prader-Willi, which would have made it the first marketed drug for the disease since human growth hormone over a decade ago.

Startup 40
article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

Two days later, it paid AstraZeneca $550 million upfront for the rights to a group of antibiotics either already on the market or in late-stage testing. It will retain the PixarBio name and aims to start trading on the over-the-counter market during the second week of September.

Pricing 40
article thumbnail

Pacific Coast Business Times - Hall of Fame Announced

SoCal Delicious

• Jack Gilbert , once the chief executive officer of a large Los Angeles-based corporation, later founded Thousand Oaks Land Development and played a major role in the development of Thousand Oaks area, leading that city’s emergence as a major business and corporate center.